Using transgenic plant-based production and delivery systems to develop an avian influenza vaccine

使用转基因植物生产和输送系统开发禽流感疫苗

• 批准号: LP0667534
• 负责人: Prof Richard Strugnell
• 金额: $ 32.84万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2006
• 资助国家: 澳大利亚
• 起止时间: 2006-04-01 至 2009-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0667534
• 关键词: Using; transgenic; plant; based; production

This project aims to provide proof-of-concept for the rapid production of plant-made vaccines of high strategic value to the poultry industry. Plant-made AI vaccines would help safeguard primary industries in Australia from exotic influenza strains and shield rural communities from the impact of stock losses. This collaboration will also contribute to the Molecular Farming industry by ensuring that Australian interests are considered as this frontier technology tackles the challenges of turning academic research into marketable products. The key features of an oral plant-made AI vaccine, including rapid and non-egg based production, also make this an attractive technology for the future development of swine and human influenza vaccines.

该项目旨在为快速生产对家禽业具有高战略价值的植物疫苗提供概念验证。植物制造的禽流感疫苗将有助于保护澳大利亚的初级产业免受外来流感毒株的影响，并保护农村社区免受库存损失的影响。这项合作也将有助于分子农业产业，确保澳大利亚的利益被认为是这一前沿技术解决了将学术研究转化为可销售产品的挑战。口服植物制成的AI疫苗的关键特征，包括快速和非蛋基生产，也使其成为未来开发猪和人流感疫苗的有吸引力的技术。